$HCMC
Healthier Choices Management Corp.

2021 Q1 Form 10-Q Financial Statement

#000084485621000046 Filed on May 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $3.466M $4.036M
YoY Change -14.13% -7.85%
Cost Of Revenue $1.975M $2.328M
YoY Change -15.17% -6.01%
Gross Profit $1.491M $1.708M
YoY Change -12.72% -10.25%
Gross Profit Margin 43.01% 42.31%
Selling, General & Admin $2.023M
YoY Change
% of Gross Profit 135.7%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $136.6K $147.8K
YoY Change -7.6% -2.94%
% of Gross Profit 9.16% 8.66%
Operating Expenses $2.023M $2.372M
YoY Change -14.73% -20.67%
Operating Profit -$532.2K -$664.5K
YoY Change -19.91% -38.9%
Interest Expense -$46.79K -$26.73K
YoY Change 75.05% 10.14%
% of Operating Profit
Other Income/Expense, Net -$164.1K -$26.81K
YoY Change 512.14% 7.36%
Pretax Income -$696.3K -$691.3K
YoY Change 0.72% -37.86%
Income Tax
% Of Pretax Income
Net Earnings -$696.3K -$691.3K
YoY Change 0.72% -37.86%
Net Earnings / Revenue -20.09% -17.13%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 244.2B 69.72B
Diluted Shares Outstanding 244.2B 69.72B

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.365M $3.177M
YoY Change 68.88% -47.58%
Cash & Equivalents $5.316M $3.163M
Short-Term Investments $48.86K $14.14K
Other Short-Term Assets $237.8K $248.7K
YoY Change -4.36% -43.95%
Inventory $1.701M $1.717M
Prepaid Expenses
Receivables $56.75K $66.48K
Other Receivables $0.00 $0.00
Total Short-Term Assets $7.360M $5.209M
YoY Change 41.3% -38.63%
LONG-TERM ASSETS
Property, Plant & Equipment $223.0K $304.3K
YoY Change -26.72% -94.2%
Goodwill $916.0K $956.0K
YoY Change -4.18%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $88.60K $142.9K
YoY Change -38.01% -0.48%
Total Long-Term Assets $6.625M $8.147M
YoY Change -18.68% -14.55%
TOTAL ASSETS
Total Short-Term Assets $7.360M $5.209M
Total Long-Term Assets $6.625M $8.147M
Total Assets $13.99M $13.36M
YoY Change 4.71% -25.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $813.9K $999.6K
YoY Change -18.58% -22.9%
Accrued Expenses $483.5K $546.7K
YoY Change -11.56% 4.11%
Deferred Revenue $18.17K $23.07K
YoY Change -21.23%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $842.2K $2.282M
YoY Change -63.1% 6.12%
Total Short-Term Liabilities $2.158M $3.852M
YoY Change -43.98% -35.11%
LONG-TERM LIABILITIES
Long-Term Debt $778.4K $798.6K
YoY Change -2.53% -26.12%
Other Long-Term Liabilities $3.001M $3.414M
YoY Change -12.08% -7.27%
Total Long-Term Liabilities $3.780M $4.212M
YoY Change -10.27% -11.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $2.158M $3.852M
Total Long-Term Liabilities $3.780M $4.212M
Total Liabilities $5.937M $8.064M
YoY Change -26.37% -24.62%
SHAREHOLDERS EQUITY
Retained Earnings -$33.06M -$29.33M
YoY Change 12.71%
Common Stock $30.77M $7.250M
YoY Change 324.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.048M $5.292M
YoY Change
Total Liabilities & Shareholders Equity $13.99M $13.36M
YoY Change 4.71% -25.89%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$696.3K -$691.3K
YoY Change 0.72% -37.86%
Depreciation, Depletion And Amortization $136.6K $147.8K
YoY Change -7.6% -2.94%
Cash From Operating Activities -$656.4K -$199.3K
YoY Change 229.36% -81.21%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $89.42K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $13.18K $7.360K
YoY Change 79.08% -82.25%
Cash From Investing Activities -$17.68K -$92.86K
YoY Change -80.96% -323.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $77.50K $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 3.065M -70.57K
YoY Change -4442.59% 49.49%
NET CHANGE
Cash From Operating Activities -656.4K -199.3K
Cash From Investing Activities -17.68K -92.86K
Cash From Financing Activities 3.065M -70.57K
Net Change In Cash 2.391M -362.7K
YoY Change -759.1% -65.99%
FREE CASH FLOW
Cash From Operating Activities -$656.4K -$199.3K
Capital Expenditures $0.00 $89.42K
Free Cash Flow -$656.4K -$288.7K
YoY Change 127.35% -72.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
813870
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1085663
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23675
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
56754
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5330562
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3955039
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
1875
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
81944
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
71170000000
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
306023000000
CY2021Q1 us-gaap Assets
Assets
13985537
CY2020Q4 us-gaap Assets
Assets
11874993
CY2020Q4 us-gaap Assets Current
AssetsCurrent
3007192
CY2021Q1 us-gaap Assets Current
AssetsCurrent
7360395
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5316169
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
925475
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2390694
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-362720
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3525415
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2925475
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5316169
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3162695
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
307700000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
143800000000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
750000000000
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
307700000000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
143800000000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
30772608
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
14384084
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
287069
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
369706
CY2020Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
21262
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
26823
CY2021Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18170
CY2020Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
23067
CY2021Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18170
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
21262
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
147834
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
136597
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1248352
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1150329
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2339665
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2339665
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
130841
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
130841
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1189336
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1091313
CY2021Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
125341
CY2021Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
26126
CY2020Q1 us-gaap Gain Loss On Investments
GainLossOnInvestments
-9857
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-117296
CY2021Q1 us-gaap Goodwill
Goodwill
916000
CY2020Q4 us-gaap Goodwill
Goodwill
916000
CY2021Q1 us-gaap Gross Profit
GrossProfit
1490710
CY2020Q1 us-gaap Gross Profit
GrossProfit
1707892
CY2021Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3092
CY2020Q1 us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-3756
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-146862
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
126569
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-122765
CY2020Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
47124
CY2021Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1003
CY2020Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3958
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-48462
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-40036
CY2021Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
33079
CY2020Q1 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1081
CY2020Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-16872
CY2021Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-72915
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
35256
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
81313
CY2021Q1 us-gaap Inventory Net
InventoryNet
1700784
CY2020Q4 us-gaap Inventory Net
InventoryNet
1749246
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
11874993
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
13985537
CY2020Q4 us-gaap Liabilities
Liabilities
9617625
CY2021Q1 us-gaap Liabilities
Liabilities
5937496
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2157750
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5654095
CY2021Q1 us-gaap Line Of Credit Facility Collateral Fees Amount
LineOfCreditFacilityCollateralFeesAmount
2000000
CY2021Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2020Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
2000000
CY2020Q4 us-gaap Loans Payable Current
LoansPayableCurrent
2072484
CY2021Q1 us-gaap Loans Payable Current
LoansPayableCurrent
842228
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
4921493
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
1620639
CY2021Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
778411
CY2020Q4 us-gaap Long Term Loans Payable
LongTermLoansPayable
849009
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-199288
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-656370
CY2021Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
291333
CY2021Q1 us-gaap Number Of Stores
NumberOfStores
8
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3114521
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3001335
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
474686
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
483482
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
2372381
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2022883
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3955886
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4078621
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-532173
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-664489
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
88595
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-691294
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-696258
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-17677
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92858
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3064741
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-70574
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-26805
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-164085
CY2020Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
304511
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
89598
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-76
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0
CY2021Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
30855
CY2020Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
10805
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
89415
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Reclassification</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain amounts in the condensed consolidated financial statements and related notes have been reclassified to conform to the current year presentation. Such reclassifications do not impact the Company's previously reported financial position or net income (loss).</div></div><div><br /></div></div></div>
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
77500
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2020Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0
CY2021Q1 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
5000000
CY2020Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
7362
CY2021Q1 us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
13178
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
230719
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
222999
CY2020Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0
CY2021Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
2000000
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
12759
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
70574
CY2021Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
0
CY2020Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
2000000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33055129
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-32358871
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3465753
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4036172
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
81944
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1875
CY2021Q1 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.0011
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
48857
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
22731
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
0
CY2021Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
77500
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
775000000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1407556
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1290261
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
2257368
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
8048041
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
5901731
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
5292381
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic; font-weight: bold;">Use of Estimates in the Preparation of the Financial Statements</div><div><br /></div><div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><!--Anchor--><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, and the reported amounts of net revenue and expenses during the reporting periods. Actual results could differ from those estimates. These estimates and assumptions include allowances, reserves and write-downs of inventory, valuing equity securities and hybrid instruments, share-based payment arrangements, deferred taxes and related valuation allowances, and the valuation of the assets and liabilities acquired in business combinations. Certain of management&#8217;s estimates could be affected by external conditions, including those unique to our industry, and general economic conditions. It is possible that these external factors could have an effect on our estimates that could cause actual results to differ from our estimates. The Company re-evaluates all of its accounting estimates at least quarterly based on these conditions and records adjustments when necessary.</font></div><div><br /></div></div></div>
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69716324179
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
244246983178
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
244246983178
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69716324179
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Healthier Choices Management Corp.
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000844856
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
307926082074
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 hcmc Prepaid Expense And Vendor Deposits Current
PrepaidExpenseAndVendorDepositsCurrent
237831
CY2020Q4 hcmc Prepaid Expense And Vendor Deposits Current
PrepaidExpenseAndVendorDepositsCurrent
286065
CY2020Q1 hcmc Contract With Customer Liability Breakage Recognized
ContractWithCustomerLiabilityBreakageRecognized
-556
CY2021Q1 hcmc Contract With Customer Liability Breakage Recognized
ContractWithCustomerLiabilityBreakageRecognized
-134
CY2020Q1 hcmc Contract With Customer Liability Redeemed
ContractWithCustomerLiabilityRedeemed
63509
CY2021Q1 hcmc Contract With Customer Liability Redeemed
ContractWithCustomerLiabilityRedeemed
49585
CY2021Q1 hcmc Contract With Customer Liability Issued
ContractWithCustomerLiabilityIssued
46627
CY2020Q1 hcmc Contract With Customer Liability Issued
ContractWithCustomerLiabilityIssued
60309
CY2021Q1 hcmc Contract Liabilities Expected Recognition Period
ContractLiabilitiesExpectedRecognitionPeriod
P24M
CY2021Q1 hcmc Stock Canceled During Period Value Cancellation Of Restricted Stock To Officer
StockCanceledDuringPeriodValueCancellationOfRestrictedStockToOfficer
0
CY2021Q1 hcmc Stock Canceled During Period Value Cancellation Of Awarded To Board Members
StockCanceledDuringPeriodValueCancellationOfAwardedToBoardMembers
0
CY2021Q1 hcmc Stock Issued During Period Value Issuance Of Restricted Stock To Officer
StockIssuedDuringPeriodValueIssuanceOfRestrictedStockToOfficer
0
CY2021Q1 hcmc Stock Issued During Period Value Issuance Of Awarded To Board Members
StockIssuedDuringPeriodValueIssuanceOfAwardedToBoardMembers
0
CY2020Q1 hcmc Increase Decrease In Prepaid Expense And Vendor Deposits
IncreaseDecreaseInPrepaidExpenseAndVendorDeposits
-21171
CY2021Q1 hcmc Increase Decrease In Prepaid Expense And Vendor Deposits
IncreaseDecreaseInPrepaidExpenseAndVendorDeposits
-48234
CY2020Q1 hcmc Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
158724
CY2021Q1 hcmc Amortization Of Right Of Use Asset
AmortizationOfRightOfUseAsset
122735
CY2020Q1 hcmc Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
140374
CY2021Q1 hcmc Increase Decrease In Lease Liability
IncreaseDecreaseInLeaseLiability
104390
CY2020Q1 hcmc Issuance Of Common Stock In Connection With Cashless Exercise Of Series Warrants
IssuanceOfCommonStockInConnectionWithCashlessExerciseOfSeriesWarrants
0
CY2021Q1 hcmc Issuance Of Common Stock In Connection With Cashless Exercise Of Series Warrants
IssuanceOfCommonStockInConnectionWithCashlessExerciseOfSeriesWarrants
1407556
CY2021Q1 hcmc Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
106531
CY2021Q1 hcmc Exchange Of Notes For Shares Of Common Stock
ExchangeOfNotesForSharesOfCommonStock
1172964218

Files In Submission

Name View Source Status
0000844856-21-000046-index-headers.html Edgar Link pending
0000844856-21-000046-index.html Edgar Link pending
0000844856-21-000046.txt Edgar Link pending
0000844856-21-000046-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
form10q.htm Edgar Link pending
hcmc-20210331.xml Edgar Link completed
hcmc-20210331.xsd Edgar Link pending
hcmc-20210331_cal.xml Edgar Link unprocessable
hcmc-20210331_def.xml Edgar Link unprocessable
hcmc-20210331_lab.xml Edgar Link unprocessable
hcmc-20210331_pre.xml Edgar Link unprocessable
image1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending